With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

Immunocore Holdings hired a non-executive director on its board as the company's chief financial officer. The U.K. biotechnology company Thursday said Travis Coy has been appointed CFO and head of ...

and human data to transfo Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In addition ...

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, ...

The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...

Junior Achievement USA announced today that it has received a $22.5 million grant from Lilly Endowment Inc. to enhance existing curricula and infuse character development within JA's learning ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...

Eli Lilly and Company. Although the gifts of stock remain a financial bedrock of the endowment, it is a separate entity from the company, with a distinct governing board, staff and location. In ...

Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...